Spotlight issue

22nd April 2020 / Competitiveness / Health Care

BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates

  • First COVID-19-related clinical trial to start in Germany
  • Initial dose escalation phase to target dose range of 1µg to 100µg
  • Clinical supply from BioNTech’s GMP-certified mRNA production facilities in Europe
  • Four vaccine candidates to enter clinical development

22nd April 2020 / Competitiveness / Tax & Finance

Financial Statements in the Time of the Coronavirus

We have not yet recovered from how our world virtually changed overnight. From a colourful world of abundance and wealth, we suddenly find ourselves in a world where we have to avoid personal contact, cannot move freely and fear for our and our family’s health. Despite all the big fears and smaller ones, many see the new situation as an opportunity. Suddenly we all communicate via modern technology, organise video- and teleconferences, scan, e-mail and find out that it might actually not be necessary to keep binders full of papers.

22nd April 2020 / Competitiveness / Macroeconomic Indicators, Economic Growth

Eurozone lockdown live: The risk of an asymmetric recovery

Judging from mobility data, the lockdown measures in the eurozone seem to have different impacts across the countries. With some countries easing the lockdown measures, while others remain locked down for longer, the risk of an asymmetric recovery has increased

21st April 2020 / Competitiveness / Technology, R&D and Innovation

OECD: Tracking and tracing COVID: Protecting privacy and data while using apps and biometrics

As  COVID-19  continues  to  take  human  lives  and  jolt  the  global  economy,  governments  are  urgently seeking innovative new tools to inform policy and tackle the crisis.

21st April 2020 / Good governance / Legal Reform and Transparency

Coronavirus: Impact of operational restrictions on commercial and residential leases in the Czech Republic

Due to Coronavirus (SARS CoV-2), the operation of retail shopping facilities in the Czech Republic is affected by operational restrictions imposed by the public authorities from 12 March 2020 to protect public health and safety. The Czech Government also introduced bills which prohibit the termination of leases due to non-payment of the rent, provided it is caused by restrictions imposed by the public authorities in relation to the pandemic.

Strategic Directions for Czech Economic Policy

  1. 1) Transition to High-Tech Manufacturing
  2. 2) The City Campus as Idea Factory
  3. 3) Government Programs That Drive Innovation
  4. 4) Government as a Competitive Advantage

Advocacy Priorities for 2020-2022 
People, Technology, Infrastructure, Cities, Government


2020 Actions Recommended in Areas:

1. Immigration.

2. Adult (post-graduate) Education and Training.

3. Programming as the Required Language.

4. Private Research Investment.

5. Housing Plan.

6. Establishing Policy Objectives for Research.

7. Establishing Databases for Tracking Public Policy Outcomes.

8. Public Procurement as an Innovation Tool.

9. A Government Competitiveness Scorecard.


Read the document in English and Czech.

Policy pipeline

In Policy Pipeline policy developments in the Czech Republic and abroad are monitored to bring better understanding of current topics and trends.

Members of the American Chamber of Commerce in the Czech Republic